Skip to main content
Moogene Medi Co., Ltd. logo

Moogene Medi Co., Ltd. — Investor Relations & Filings

Ticker · 322970 ISIN · KR7322970005 KO Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2020-06-25 Audit Report / Informat…
Country KR South Korea
Listing KO 322970

About Moogene Medi Co., Ltd.

http://moogene.com/eng/

Moogene Medi Co., Ltd. is a biotechnology company specializing in nanomedicine and the development of advanced drug delivery systems. The company focuses on its proprietary Lipid Nanoparticle (LNP) carrier system and other nano-bio technologies to safely and effectively transport a range of therapeutic agents, including genes, chemicals, and proteins. Its primary mission is to create novel therapeutics for severe and incurable diseases. The development pipeline includes gene therapies for conditions such as cancer, metabolic diseases, and androgenic alopecia, utilizing technologies like CRISPR/Cas9 gene editing. Moogene Medi operates an aseptic, GMP-grade facility, providing end-to-end support from initial research to GMP-scale production for clinical studies.

Recent filings

Filing Released Lang Actions
사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Mujin Medi' (주식회사 무진메디) for the fiscal years 2018 and 2019. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an annual report (10-K) or an earnings release (ER). FY 2019
2020-06-25 Korean
감사보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Mujin Medi' (주식회사 무진메디) for the fiscal years 2018 and 2019. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an annual report (10-K) or an earnings release (ER). FY 2019
2020-04-03 Korean
감사보고서 (2018.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company '주식회사 무진메디' for the fiscal year 2018. It includes the independent auditor's opinion, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and notes to the financial statements. While it contains financial data, it is a formal audit report issued by an accounting firm (이촌회계법인) rather than a company-issued 10-K or an interim report. Therefore, it is classified as an Audit Report. FY 2018
2019-04-05 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.